|
ACXP
|
Acurx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ARMP
|
Armata Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
CTXR
|
Citius Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ELAN
|
Elanco Animal Health Incorporated
|
US
|
NYSE
|
|
ELAT
|
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
|
US
|
NYSE
|
|
GILD
|
Gilead Sciences, Inc.
|
US
|
NASDAQ
|
|
GSK
|
GlaxoSmithKline PLC
|
US
|
NYSE
|
|
IDXX
|
IDEXX Laboratories, Inc.
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
US
|
NASDAQ
|
|
LCI
|
Lannett Co Inc
|
US
|
NYSE
|
|
LLY
|
Eli Lilly and Company
|
US
|
NYSE
|
|
MCRB
|
Seres Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRK
|
Merck & Company, Inc.
|
US
|
NYSE
|
|
MTNB
|
Matinas Biopharma Holdings, Inc.
|
US
|
AMEX
|
|
NBRV
|
Nabriva Therapeutics AG
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|
|
NVS
|
Novartis AG
|
US
|
NYSE
|
|
OGEN
|
Oragenics, Inc.
|
US
|
AMEX
|
|
OPGN
|
OpGen, Inc.
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|